SCHEMBL25459568

SCHEMBL25459568

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4sc(-c5cccc(-c6ccc7c8ccccc8c8ccccc8c7c6)c5)nc4c3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.46
▸ RAB9A P51151 9/20 0.44
▸ NFKB1 P19838 8/20 0.44
▸ NFKB2 Q00653 8/20 0.44
▸ RELA Q04206 8/20 0.44
▸ NPC1 O15118 6/20 0.44
▸ HPGD P15428 4/20 0.44
▸ STAT1 P42224 1/20 0.44
▸ SMN1; SMN2 Q16637 8/20 0.44
▸ MAPT P10636 7/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 3/20 0.44
▸ TP53 P04637 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ GAA P10253 3/20 0.43
▸ GFER P55789 1/20 0.43
▸ APP P05067 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25459565 0.94 RAB9A (0.48) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL25755193 0.93 SMN1; SMN2 (0.49) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL25459747 0.90 APP (0.51) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL27049208 0.89 RAB9A (0.54) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL27049229 0.88 RAB9A (0.53) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL25755286 0.87 KDM4E (0.37) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL26535744 0.84 RAB9A (0.61) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL26535822 0.84 RAB9A (0.61) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL26535825 0.84 RAB9A (0.61) KDM4ERAB9ANFKB1NFKB2RELA
SCHEMBL27258765 0.84 RAB9A (0.61) KDM4ERAB9ANFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2023-07-06 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed
US-20230145469-A1 ORGANIC LIGHT EMITTING ELEMENT LG DISPLAY CO., LTD. (KR) 2023-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217814-A1 ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME AOX1, XDH, PPOX KDM4E 2446/4885RAB9A 3117/4885NFKB1 2599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback